|
Avasimibe |
|
Escherichia Salmonella |
TTSS secreted effectors TTSS-2 secreted effectors |
Preclinical (in vivo) Preclinical (in vivo) |
Hasan MK, et al. 2022. Pathogens
|
|
Compound 7b (internal name in literature) |
Depiction based on curated SMILES
N
Cl
Cl
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 7d (internal name in literature) |
Depiction based on curated SMILES
N
Br
Br
CH
3
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Compound 8j (internal name in literature) |
Depiction based on curated SMILES
CH
3
N
S
N
|
Salmonella |
Biofilm |
Preclinical (in vivo) |
Woolard KJ, et al. 2022. Eur J Med Chem |
|
Geraniol |
Depiction based on curated SMILES
CH
3
HO
CH
3
CH
3
|
Shigella |
DsbA |
Preclinical (in vivo) |
Mirza ZRMH, et al. 2018. Virulence |
|
4-methyl-2-(4-methylphenyl)-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
Depiction based on curated SMILES
N
N
O
N
CH
3
O
N
N
N
CH
3
O
O
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
4-methyl-2-phenyl-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
Depiction based on curated SMILES
N
N
N
O
N
O
N
O
CH
3
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
6-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-(pyridin-4-yl)pyridazin-3-amine |
Depiction based on curated SMILES
N
N
N
N
H
CH
3
N
N
O
O
S
CH
3
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
N-(1,3-benzodioxol-5-ylmethyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]-4-piperidinecarboxamide |
Depiction based on curated SMILES
O
O
HN
N
H
O
S
O
O
N
O
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
N-(furan-2-ylmethylcarbamoyl)-2-(4-oxobenzo[g]quinazolin-3-yl)acetamide |
Depiction based on curated SMILES
O
N
H
O
HN
O
O
N
N
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
| | |